A Study for the Treatment of Painful Diabetic Neuropathy

Status Completed

Clinical Trial Summary

The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.

Clinical Trial Description

The protocol will assess the efficacy and safety of duloxetine. It will also look at how duloxetine affects quality of life. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00058968
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 3
Start date	October 2002
Completion date	March 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04988321` - Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms	N/A
Completed	`NCT00385671` - An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain	Phase 4
Completed	`NCT00159679` - Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy	Phase 4
Completed	`NCT00141401` - Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.	Phase 3
Active, not recruiting	`NCT04469270` - Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00553475` - Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00381719` - Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT00539175` - Treatment of Painful Diabetic Neuropathy With Photon Stimulation	N/A
Completed	`NCT05029297` - Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.	Phase 3
Completed	`NCT02215252` - A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)	Phase 2
Completed	`NCT00785577` - A Study for Treatment of Pain in Patients With Diabetic Neuropathy.	Phase 2
Completed	`NCT00858351` - Thermal Biofeedback for the Treatment of Diabetic Neuropathy	N/A
Completed	`NCT03047278` - Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.	Phase 4
Completed	`NCT01628627` - Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy	Phase 4
Completed	`NCT03315598` - Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain	N/A
Completed	`NCT01057693` - Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT01564459` - Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)	Phase 2
Recruiting	`NCT01214590` - Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01089556` - A Study in Painful Diabetic Neuropathy	Phase 3
Completed	`NCT00501202` - Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).	Phase 2